Double-blind, placebo-controlled comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.

scientific article published on 25 November 2009

Double-blind, placebo-controlled comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1177/0269881109106953
P698PubMed publication ID19939870

P2093author name stringGary Evoniuk
Jack G Modell
Alok Krishen
Alfred Le Clus
Hans-Peter Wunderlich
Karen Hewett
Michelle D Gee
P2860cites work15 years of clinical experience with bupropion HCl: from bupropion to bupropion SR to bupropion XLQ24530904
A Review of the Neuropharmacology of Bupropion, a Dual Norepinephrine and Dopamine Reuptake InhibitorQ24563250
A placebo-controlled comparison of the antidepressant efficacy and effects on sexual functioning of sustained-release bupropion and sertralineQ28377576
Sexual dysfunction associated with the treatment of depression: a placebo-controlled comparison of bupropion sustained release and sertraline treatmentQ28377591
Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.Q33994367
Efficacy of venlafaxine in geriatric depressionQ34093713
Double-blind comparison of bupropion sustained release and sertraline in depressed outpatientsQ34454456
A double-blind comparison between bupropion XL and venlafaxine XR: sexual functioning, antidepressant efficacy, and tolerabilityQ34566285
Depression in late life: review and commentaryQ35084435
The safety and tolerability of venlafaxine hydrochloride: analysis of the clinical trials databaseQ41093446
A placebo-controlled comparison of the effects on sexual functioning of bupropion sustained release and fluoxetineQ43717721
Selective effects of serotonergic psychoactive agents on gastrointestinal functions in healthQ44253289
Bupropion and venlafaxine responders differ in pretreatment regional cerebral metabolism in unipolar depressionQ45251035
Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.Q46477533
P433issue8
P407language of work or nameEnglishQ1860
P921main subjectplaceboQ269829
P304page(s)1209-1216
P577publication date2009-11-25
P1433published inJournal of PsychopharmacologyQ6295819
P1476titleDouble-blind, placebo-controlled comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.
P478volume24

Reverse relations

cites work (P2860)
Q48868283A model to incorporate genetic testing (5-HTTLPR) in pharmacological treatment of major depressive disorders
Q21144599Adjunctive atypical antipsychotic treatment for major depressive disorder: a meta-analysis of depression, quality of life, and safety outcomes
Q26747727Bupropion: a systematic review and meta-analysis of effectiveness as an antidepressant
Q37810766Drug treatment for mood disorders in pregnancy
Q37309556Effects of levomilnacipran extended-release on motivation/energy and functioning in adults with major depressive disorder
Q26864531Efficacy, tolerability, and acceptability of bupropion for major depressive disorder: a meta-analysis of randomized-controlled trials comparison with venlafaxine
Q57820341Gebelikte Psikotrop İlaç Kullanımı: Bir Güncelleme
Q37503551Less is more in antidepressant clinical trials: a meta-analysis of the effect of visit frequency on treatment response and dropout
Q46182025Meta-analysis: Risk of hyperhidrosis with second-generation antidepressants
Q39402042Patterns of use and toxicity of new para-halogenated substituted cathinones: 4-CMC (clephedrone), 4-CEC (4-chloroethcatinone) and 4-BMC (brephedrone).
Q90295943Population Pharmacokinetics, Safety and Tolerability of Extended-Release Bupropion and Its Three Metabolites in Chinese Healthy Volunteers
Q38714376Problems in the Descriptions of the Psychiatric Inclusion and Exclusion Criteria in Publications of Antidepressant Efficacy Trials: A Qualitative Review and Recommendations for Improved Clarity
Q34240696Randomized, placebo-controlled trials of antidepressants for acute major depression: thirty-year meta-analytic review
Q38817431The Effects of Newer Antidepressants on Occupational Impairment in Major Depressive Disorder: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Q37694366The effect of vortioxetine on overall patient functioning in patients with major depressive disorder
Q34226014The efficacy and tolerability of bupropion in the treatment of major depressive disorder
Q28300843The noradrenergic action in antidepressant treatments: pharmacological and clinical aspects

Search more.